Descubra las mejores clínicas y precios de Oncología en India 2026

En 16 meses, el equipo de nuestra clínica realizó 410 cirugías robóticas con una tasa de éxito superior al 99%. Se trata de intervenciones robóticas para tumores malignos y benignos, así como cirugías bariátricas. Los pacientes prefieren la cirugía robótica debido a sus altas tasas de éxito y mínimo dolor.

El Consejo Indio de Investigación Médica predice alrededor de 1.390.000 nuevos casos de cáncer en 2021. Esto hace que las enfermedades malignas sean una de las más comunes en la India. El principal problema en el tratamiento del cáncer son los costes excesivos. India proporciona las últimas técnicas (quirúrgicas y no quirúrgicas) a un costo menor que la mayoría de los países. Al mismo tiempo, la calidad y la eficacia del tratamiento son igualmente altas .

La recuperación total del cáncer es un tema discutible. Si una persona tenía una enfermedad oncológica, siempre existe la posibilidad de que regrese. Durante 14 años, hemos tratado a más de 90 000 pacientes con tumores malignos en Nasik, Maharashtra, India. En muchos de ellos, la enfermedad no se manifestó durante todo el período de observación. Algunos tuvieron recaídas, que, gracias a nuestro tratamiento, entraron en remisión. Lamentablemente, una pequeña proporción de pacientes con cáncer avanzado no superó la enfermedad. Nuestro objetivo principal es curar el cáncer y prolongar la vida tanto como sea posible. Al mismo tiempo, independientemente de la cantidad de años que el paciente pueda vivir, la calidad de su vida está por encima de todo.

A tumour board is a multidisciplinary team of specialists. It includes surgeons, oncologists, and pathologists who decide on a cancer treatment plan together. For oncology cases in India, this review is the standard approach. It ensures balanced care by removing individual bias and following international guidelines.

• Multidisciplinary team: Includes experts in medical, surgical, and radiation oncology, plus radiology and pathology.
• Clinical benefit: Boards catch staging errors and adjust the timing of chemotherapy, surgery, or radiation.
• Quality signal: Structured reviews at centres like Artemis Hospitals suggest higher coordinated decision-making standards.
• Efficiency: One review replaces multiple second opinions, saving time for complex or rare cases.

Bookimed Expert Insight: Patient volume directly affects tumour board efficacy. Clinics like Apollo Hospital Indraprastha and Manipal Hospitals serve over 1,000,000 patients annually. This case volume means their boards have reviewed almost every cancer subtype. This gives them a deeper database for comparison than smaller, local facilities.

Patient Consensus: Patients in India feel more confident when a panel reviews their actual imaging and pathology. They appreciate friendly staff and doctors who clearly explain these collaborative plans. Many suggest having a companion to help navigate hospital logistics.

Leading Indian oncologists provide remote second opinions through digital consultations. Patients can access specialist reviews for various cancers, including leukaemia and breast tumours. They do this by submitting pathology reports and radiology scans. These reviews often include a multidisciplinary tumour board assessment to confirm diagnosis and staging.

• Specialist expertise: Dr Sidharth Sahni serves as a breast surgical oncologist for multiple international embassies.
• Expert review: Dr Surender Dabas has performed over 8,000 head-neck and thoracic cancer surgeries.
• Bone marrow insights: Dr Dharma Choudhary leads the Bone Marrow Transplant Department at BLK Hospital.
• Radiation oncology: Dr S Hukku has over 40 publications in international scientific journals.

Bookimed Expert Insight: Clinics like Artemis or Manipal handle many international patients. These centres have streamlined systems for remote file review. They treat 1,000,000+ patients annually, which leads to faster processing of digital files. This setup allows specialists to return structured treatment recommendations within days without immediate travel.

Patient Consensus: Patients find that Indian specialists explain all treatment options clearly. They provide new drug suggestions and hope for recovery. While some mention hospital wait times, they praise the surgical expertise and the thorough digital test results.

Indian oncology centres provide precision therapies including immunotherapy and targeted therapy. Major facilities in Delhi and Bengaluru use next-generation sequencing to create personalised plans. These treatments target specific genetic mutations and proteins to treat breast, lung, and blood cancers effectively.

• Therapy range: Immunotherapy ranges from Precio a consultar to Precio a consultar for various stages.
• Specific drugs: Immunotherapy including Keytruda costs between Precio a consultar and Precio a consultar per cycle.
• Diagnostic tools: PET/CT scans for precise staging cost from $400 to $600.
• Personalised care: Specialists like Dr Sarat Chandra P at Manipal Hospitals focus on precision medicine.

Bookimed Expert Insight: India is becoming a hub for indigenous precision medicine breakthroughs. Global drug brands are available. However, homegrown innovations like NexCAR19 therapy offer cellular treatment at significantly lower costs than imported alternatives. This makes high-level biological therapy accessible to international patients who find Western prices prohibitive.

Patient Consensus: Patients in India find the clinical level of surgery and drug selection impressive. They recommend having support for logistics. They also note that medical expertise and English-speaking doctors provide high-quality care.

Indian oncology centres use the same primary chemotherapy medications as Australia. Both nations follow international standards like guidelines from NCCN and ESMO. While active chemical compounds are identical, India relies on domestically produced generics. This reduces medical costs while maintaining efficacy for standard cancer treatments.

• Drug overlap: Clinics use standard agents including Cisplatin, Paclitaxel, and 5-Fluorouracil.
• Generic manufacturing: Indian facilities primarily use high-quality local generics instead of originators.
• Regulatory speed: India often approves and stocks new immunotherapy drugs very rapidly.
• Accredited facilities: Leading centres like Apollo Hospital Indraprastha hold JCI accreditation.

Bookimed Expert Insight: Leading Indian specialists like Dr Sidharth Sahni at Apollo Hospital serve high-level Australian entities. This helps local treatment plans align with Western expectations. Our data shows JCI-accredited clinics in major cities manage 1,000,000+ international patients yearly. These high volumes mean hospital pharmacies stock fresh batches of chemotherapy drugs. This constant turnover helps maintain medicine potency at its peak.

Patient Consensus: Patients find that Indian oncologists prescribe innovative drugs and internationally recognised regimens. These plans closely match Australian protocols. The clinical care and surgical results are highly professional. However, navigating hospital organisation is easier with an accompanying person.

Oncology patients in India typically move from consultation to diagnosis within 32 days. Treatment starts quickly after, averaging 20 days. Private centres like Apollo Hospital Indraprastha often fast-track this process. They coordinate staging and surgery within 7 to 14 days for urgent cases.

• Diagnostic turnaround: Definitive tests including biopsy and PET-CT usually take about 32 days.
• Treatment initiation: Median time from confirmed diagnosis to starting therapy is 20 days.
• Clinical variation: Urgent haematological cases start in 11 days. Radiotherapy requires 27–30 days.
• Hospital systems: Integrated centres like Manipal Hospitals coordinate pathology and radiology to reduce delays.

Bookimed Expert Insight: Large Indian networks often re-validate pathology slides from smaller clinics for accuracy. Patients can save roughly 5 to 7 days by bringing original biopsy slides to their first appointment. This prevents the need for a new biopsy before starting treatment.

Patient Consensus: Patients note that major hospitals move very fast once you arrive. While repeat testing is common for safety, international visitors appreciate how specialists coordinate care in one location. India provides a good level of care at high-volume tertiary centres.

International patients access supportive and palliative care through India’s major private hospital networks and oncology hubs. Leading centres integrate pain management, nutritional counselling, and psychosocial support into treatment. Facilities like Apollo Hospital Indraprastha and Manipal Hospitals use specialised international desks to coordinate these services.

• Multidisciplinary approach: Major hospitals include symptom relief in active chemotherapy and radiotherapy protocols.
• Specialised pain management: Care teams use medications and localised therapies for chronic pain.
• Psychosocial resources: Counselling services help international patients and their families navigate intensive treatment.
• Nutritional support: Targeted dietary plans offset side effects from surgeries or systemic therapies.

Bookimed Expert Insight: India’s third-largest healthcare provider, Manipal Hospitals, manages roughly 2,000,000 patients annually. Data shows that larger systems like this or Apollo Hospital Indraprastha provide robust infrastructure. Patients should confirm that symptom management teams are available from the day of diagnosis.

Patient Consensus: Patients report that while medical treatment is high-quality, having a coordinator is essential. They note that hospital food is excellent and private bays provide comfort during recovery.

La atención médica en la India se basa en modelos rentables. La mayoría de los hospitales son privados: el 65 % del PIB anual proviene de los pagos directos de los servicios médicos.

1,4 millones de médicos brindan excelente tratamiento en el país. El 74% de la atención médica en la India es privada. Los centros médicos locales cuentan con certificados internacionales y nacionales que confirman la alta calidad de los servicios y la seguridad del paciente:

• JCI (Joint Commission International) es una organización internacional para mejorar la calidad y seguridad de los servicios médicos en todo el mundo.
• NABH (Junta Nacional para la Acreditación de Hospitales y Proveedores de Atención Médica) es una junta de calidad india que organiza la acreditación de centros médicos en el país.

Hay 39 centros médicos acreditados por JCI en la India en comparación con 20 instalaciones certificadas por JCI en Alemania y 10 hospitales en Israel.

En India , hay hoteles de diferentes rangos de precios y niveles de servicio. La mayoría de los turistas eligen hoteles de 4 y 5 estrellas. Dichos hoteles tienen todo para una estadía confortable: una variedad de comida europea y asiática, un territorio vasto y bien cuidado, animación para niños y adultos. Algunos hoteles tienen un parque acuático a disposición de los huéspedes. Los viajeros con poco presupuesto pueden permitirse reservar un hotel económico de 3 estrellas con media pensión o sin comidas.

Los pacientes extranjeros deben obtener una visa electrónica (e-Visa). La estadía máxima en el país para este tipo de visa es de 6 meses. Lea más sobre las condiciones para obtener una visa para tratamiento médico en India, lea aquí .

Una visa para un viaje a la India requiere una serie de documentos . La lista de documentos requeridos incluye:

• tarjeta de identificación
• copia de la solicitud de visa en línea
• certificado de ingresos y disponibilidad de fondos
• últimas fotos tamaño 2
• comprobante de domicilio
• reserva de vuelos y hoteles
• opinión médica sobre la necesidad de tratamiento en la India.